T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Kohl's
KSS
$2.1B
| $413M | 0.07% |
7,624,309
-528,004
| -6% | -$24.3M |
|
|
OPLN
302
Openlane
OPLN
$4.48B
| $410M | 0.07% |
21,448,623
+195,709
| +0.9% | +$3.62M |
|
|
WCG
303
DELISTED
Wellcare Health Plans, Inc.
WCG
| $410M | 0.07% |
2,038,045
-333,872
| -14% | -$64.6M |
|
304
FirstEnergy
FE
$27.1B
| $407M | 0.07% |
13,288,952
-251,807
| -2% | -$8.18M |
|
305
Insmed
INSM
$29B
| $406M | 0.07% |
13,028,622
+168,938
| +1% | +$4.99M |
|
|
CDK
306
DELISTED
CDK Global, Inc.
CDK
| $406M | 0.07% |
5,689,599
+421,489
| +8% | +$28.3M |
|
307
IQVIA
IQV
$40.1B
| $404M | 0.07% |
4,124,775
-113,553
| -3% | -$11.6M |
|
308
Jefferies Financial Group
JEF
$12.7B
| $402M | 0.07% |
16,953,940
+225,003
| +1% | +$5.19M |
|
|
NATI
309
DELISTED
National Instruments Corp
NATI
| $400M | 0.06% |
9,608,560
+108,938
| +1% | +$4.76M |
|
310
Synopsys
SNPS
$78.7B
| $399M | 0.06% |
4,685,374
+201,830
| +5% | +$17.5M |
|
311
Middleby
MIDD
$5.43B
| $395M | 0.06% |
2,929,366
-645,160
| -18% | -$78.9M |
|
|
LVNTA
312
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $395M | 0.06% |
7,286,003
-405,502
| -5% | -$23.1M |
|
313
SL Green Realty
SLG
$3.95B
| $394M | 0.06% |
4,029,701
-36,565
| -0.9% | -$3.56M |
|
314
Booz Allen Hamilton
BAH
$9.45B
| $394M | 0.06% |
10,320,137
-60,615
| -0.6% | -$2.29M |
|
315
Western Alliance Bancorporation
WAL
$8.89B
| $391M | 0.06% |
6,899,743
-481,451
| -7% | -$26.8M |
|
316
Rollins
ROL
$17.8B
| $385M | 0.06% |
18,617,087
+1,388,196
| +8% | +$28.4M |
|
317
Northrop Grumman
NOC
$81.8B
| $383M | 0.06% |
1,249,548
+40,656
| +3% | +$12.2M |
|
318
WIX.com
WIX
$2.79B
| $381M | 0.06% |
6,626,610
+1,136,403
| +21% | +$70.3M |
|
319
Eli Lilly
LLY
$1.08T
| $381M | 0.06% |
4,514,951
-55,532
| -1% | -$4.72M |
|
320
Public Storage
PSA
$60.7B
| $380M | 0.06% |
1,816,344
-79,922
| -4% | -$16.9M |
|
321
Douglas Emmett
DEI
$1.92B
| $379M | 0.06% |
9,221,577
-86,867
| -0.9% | -$3.51M |
|
322
Baxter International
BAX
$14.3B
| $378M | 0.06% |
5,850,295
+71,788
| +1% | +$4.61M |
|
323
CarGurus
CARG
$3.22B
| $374M | 0.06% |
+13,060,603
| New | +$390M |
|
|
LEXEA
324
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $373M | 0.06% |
8,403,630
+677,369
| +9% | +$32.5M |
|
325
Teledyne Technologies
TDY
$31.6B
| $372M | 0.06% |
2,053,772
-61,938
| -3% | -$10.9M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.